바로가기메뉴

본문 바로가기 주메뉴 바로가기

Influence of Obstructive Sleep Apnea on Solube Intercellular Adhesion Molecule-1 and Vascular EndothelialGrowth Factor

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2004, v.56 no.4, pp.364-373








  • Downloaded
  • Viewed

Abstract

keywords
Obstructive sleep apnea, Soluble intercellular adhesion molecule-1

Reference

1.

(1993) The occurrence of sleep disordered breathing among middle-aged adults,

2.

(2000) Sleep- related breathing disorders and cardiovascular disease,

3.

(1999) Cardiovasc morbidity in obstructive sleep apnea,

4.

(2001) Sleep apnea and cardiovascular disease,

5.

(1996) Adhesion moleꠀcules-first of two parts,

6.

(1999) Cellular adhesion moleꠀcules and atherogenesis,

7.

(2001) Immune mechanisms in atheroꠀsclerosis,

8.

(1997) New indices of ischemic heart disease and aging: studies on the serum levels of soluble intercellular adheꠀsion molecule-1(ICAM-1) and soluble vasꠀcular cell adhesion molecule-1(VCAM-1) in patients with hypercholesterolemia and ischeꠀmic heart disease,

9.

(2002) Why is soulble intercellular adhesion moleꠀcule-1 related to cardiovascular mortality?,

10.

(2002) Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis:Therapeutic Implications,

11.

(2002) Tumor angiogenesis and accessiꠀbility: Role of vascular endothelial growth factor,

12.

(1999) Interindividual heterogeneity in the hypoxic regulation of VEGF:significance for the development of the coronary artery collateral circulation,

13.

(2001) Vascular endothelial growth factor enhances atheroꠀsclerotic plaque progression,

14.

(2002) Vascular endothelial growth factor is necessary in the develꠀ opment of arteriosclerosis by recruiting/ activating monocytes in a rat model of long-term inhibition of nitric oxide synthesꠀis,

15.

(1999) Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea synꠀdrome,

16.

(2001) Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea-hypopnea syndrome,

17.

(2002) Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea,

18.

(2002) Plasma vascular endothelial growth factor (VEGF) in sleep apnea syndrome: effects of nCPAP treatment,

19.

A manual of standarized terminology ring system for sleep stages of human subꠀ University of Caliꠀ,

20.

(1992) Epidemiology of obstructive sleep apnea syndrome,

21.

(chest1988) Mortality and apnea index in obstruꠀ Experience in 385 male patients,

22.

(1988) Long-term outcome for obstructive sleep apnea syndrome patients,

23.

(1996) 전신성 고혈압을 동반한 폐쇄성 수면 무호흡증후군 환자에서 각성시와 수면중의 혈장 Catecholamines 농도변화,

24.

(1997) Meta-analysis of the morning excess of acute myocardial infarꠀction and sudden cardiac death,

25.

(1999) Atherosclerosis-an inflammatory disease,

26.

(2000) Inflammatory markers of coronary risk,

27.

(2002) Adhesion molecule in patients with coronary artery disease and moderate-to severe obstructive sleep apnea,

28.

(2003) Obstructive sleep apnoea syndrome -an oxidative stress disorder,

29.

(jimmunol1986) Induction by IL 1 and interferon-gamma and function of a natural adherence molecule,

30.

(1986) Overlapping patterns of activation of human endothelial cells by interleukin 1,tumor necrosis factor,and immune interferon,

31.

(1997) Role of alpha L beta2 integrin avidity in transendothelial chemotaxis of mononuclear cells,

32.

(1999) Evaluation of serum levels of solubilized adhesion molecules and cytokine receptors in coronary heart disease,

33.

(2000) Vascular adhesion protein-1,intercellular adhesion molecule-1 and P-selectin mediate leukocyte binding to ischemic heart in humans,

34.

(2001) Interꠀcellular adhesion molecule-1 (ICAM-1) gene expression in human T cells is regulated by phosphotyrosyl phosphatase activity. Involveꠀment of NF-κB, Ets, and palindromic interꠀferon-γ-responsive element-binding sites,

35.

(2002) Role of neutrophil NADPH oxidase in the meꠀchanism of tumor necrosis factor-α induced NF-κB activation and intercellular adhesion molecule-1 expression in endothelial cells,

36.

(2000) Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome,

37.

(1985) Gas exchange and hemoꠀdynamics during sleep,

38.

(2002) Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients,

39.

(1990) Cardiopulmonary conseꠀquences of obstructive sleep apnea,

40.

How is blood vessel growth regulated in normal and neoplastic tissue,

41.

(1994) The implications of angiogenesis for biology and therapy of canꠀcer metastasis,

42.

(1999) VEGF contriꠀbutes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells,

43.

(jexpmed1990) a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity,

44.

(1996) Migration of human monocytes in response to vascular endothelial growth factor(VEGF)is mediated via the receptor Flt-1,

45.

(1999) Vasꠀcular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells,

46.

(2001) Vascular endothelial growth factor: angiogenesis, atherogenesis or both? ,

47.

(2002) Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia,

48.

(1999) Sleep apnea in acute cerebrovascular disease: final report on 128 patients,

Tuberculosis & Respiratory Diseases